About Fermelanta
Fermelanta is a company based in Nonoichi (Japan) founded in 2022 by Hiromichi Minami, Akira Nakagawa, and Shogo Fukizaki.. Fermelanta has raised $21.43 million across 3 funding rounds from investors including Plug and Play Tech Center, Beyond Next Ventures and Keio Innovation Initiative. Fermelanta operates in a competitive market with competitors including Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.
- Headquarter Nonoichi, Japan
- Founders Hiromichi Minami, Akira Nakagawa, Shogo Fukizaki
-
Sectors
Chemicals & MaterialsHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$21.43 M (USD)
in 3 rounds
-
Latest Funding Round
-
Investors
Plug and Play Tech Center
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Fermelanta
Fermelanta has successfully raised a total of $21.43M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
-
First Round
First Round
(14 Jun 2023)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2025 | Amount | Grant - Fermelanta | Valuation |
investors |
|
| Aug, 2025 | Amount | Series A - Fermelanta | Valuation |
investors |
|
| Jun, 2023 | Amount | Seed - Fermelanta | Valuation | Beyond Next Ventures , Angel Bridge |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Fermelanta
Fermelanta has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Plug and Play Tech Center, Beyond Next Ventures and Keio Innovation Initiative. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Deep-tech investments and incubation services are provided for researchers and entrepreneurs addressing global challenges.
|
Founded Year | Domain | Location | |
|
Venture capital investments are made in innovative startups by Angel Bridge.
|
Founded Year | Domain | Location | |
|
Startups are accelerated and invested in across multiple tech sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Fermelanta
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Fermelanta
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Fermelanta Comparisons
Competitors of Fermelanta
Fermelanta operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Fermelanta
Frequently Asked Questions about Fermelanta
When was Fermelanta founded?
Fermelanta was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Where is Fermelanta located?
Fermelanta is headquartered in Nonoichi, Japan. It is registered at Nonoichi, Ishikawa, Japan.
Who is the current CEO of Fermelanta?
Shogo Fukizaki is the current CEO of Fermelanta. They have also founded this company.
Is Fermelanta a funded company?
Fermelanta is a funded company, having raised a total of $21.43M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.43M, raised on Jun 14, 2023.
What does Fermelanta do?
Fermelanta was founded in 2022 in Nonoichi, Japan, as a biotech firm. Microbial fermentation processes are employed to generate plant-based chemicals, with a focus on secondary metabolites. These compounds are applied in medicines, cosmetics, and health foods. Operations center on sustainable production methods within the biotechnology sector, supporting various industrial applications.
Who are the top competitors of Fermelanta?
Who are Fermelanta's investors?
Fermelanta has 10 investors. Key investors include Plug and Play Tech Center, Beyond Next Ventures, Keio Innovation Initiative, Angel Bridge, and SMBC Venture Capital.